Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page
- Check2 days agoChange DetectedSystem notices about government funding status and NIH operations were added, and the page revision tag updated to 3.4.1 with 3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check9 days agoChange DetectedNew metadata fields (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) and a glossary are displayed; older estimated fields and older revision data are removed.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.3.4 was added, and the keywords 'Schizophrenia' and the related topic 'MedlinePlus Genetics' along with 'Revision: v3.3.3' were removed.SummaryDifference0.2%

- Check45 days agoChange DetectedAdded a Locations section listing participating sites by state (Arkansas, California, Florida, Georgia, Louisiana, Maryland, Mississippi, Ohio, Texas) to help identify where the study is conducted.SummaryDifference0.9%

- Check67 days agoChange DetectedAdded Schizophrenia tag and MedlinePlus Genetics related topic, and updated the page revision to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check74 days agoChange DetectedRevision: v3.3.1 is now displayed on the page, and related topics such as Schizophrenia and MedlinePlus Genetics have been removed from the topics list.SummaryDifference0.2%

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.